Elekta's Nomination Committee for the 2019 Annual General Meeting

STOCKHOLM, November 15, 2018 – In accordance with the resolution passed by Elekta's (EKTA-B.ST) Annual General Meeting on August 30, 2018, the Chairman of the Board has summoned a Nomination Committee prior to the 2019 Annual General Meeting by contacting the company's four largest shareholders in terms of votes, in addition to the shareholder or shareholders represented by the Chairman himself. The procedure is described in detail in the notice of the 2018 Annual General Meeting.

The Nomination Committee consists of:

  • Laurent Leksell, in his capacity as Chairman of the Board of Elekta and representing his own and related parties’ holdings,
  • Per Colleen, appointed by the Fourth Swedish National Pension Fund,
  • Pontus Dackmo, appointed by Nordea Investment Funds,
  • Tomas Flodén, appointed by AMF and AMF Funds, and
  • Caroline Sjösten, appointed by Swedbank Robur Funds.

The Nomination Committee will appoint one of its members as Chairman.

The Nomination Committee is to present proposals for resolutions by the 2019 Annual General Meeting of Shareholders in relation to the following: Chairman of the Annual General Meeting of Shareholders, Chairman of the Board of Directors and other members of the Board of Directors, fees to the Board of Directors broken down into amounts for the Chairman of the Board of Directors, other members of the Board of Directors and members of the Board of Directors’ committees, external auditor and fees to the auditor, and where deemed necessary, proposal to amend the procedure for the Nomination Committee.

Shareholders wishing to submit proposals to Elekta’s Nomination Committee can do so by e-mail to valberedningen@elekta.com or by letter to:
Elekta AB (publ)

Att: Nomination Committee
Box 7593
SE-103 93 Stockholm
Sweden

In order for the Nomination Committee to be able to process any proposals constructively, these should be received by the Committee no later than May 1, 2019.

Elekta’s 2019 Annual General Meeting will take place in Stockholm on August 22.

# # #

About Elekta

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,700 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com.

Press Releases

Downloads

PDF Version

For further information, please contact

Oskar Bosson, Global EVP Corporate Communications and Investor Relations
Tel: +46 70 410 7180,
E-mail: Oskar.Bosson@elekta.com
Time zone: CET: Central European Time

Gunilla Öhman, Head of Investor Relations (interim)
Tel: +46 70 763 8125,
E-mail: gunilla.oehman@elekta.com
Time zone: CET: Central European Time